Medical Research · US
Foundation For Innovative New Diagnostics
Foundation For Innovative New Diagnostics reported paying Dayo Adetifa, Chief Transformation Officer/ceo, $173,587 in total compensation (FY 2024).
That places Dayo Adetifa at approximately the 24th percentile among 17 similarly sized medical research nonprofits (median $459,407).
$49,306,331Total revenue (FY 2024)
$173,587Total executive compensation
24thPercentile vs. peers
Setting executive pay for this board?
Generate a board-ready comparability report for Foundation For Innovative New Diagnostics — named comparables, percentiles, methodology, and the 26 CFR 53.4958-6 minutes language a board can use toward the rebuttable presumption.
Build the comparability report →Comparable medical research nonprofits
| Organization | State | Revenue | Total comp |
|---|---|---|---|
| American Cancer Society Cancer Action Network Inc | DC | $49,827,894 | $877,312 |
| Texas Heart Institute | TX | $50,159,295 | $828,308 |
| Northern California Institute For | CA | $52,613,082 | $356,928 |
| Alliance For Clinical Trials In Oncology | IL | $44,527,686 | $277,214 |
| Nsabp Foundation Inc | PA | $44,221,032 | $30,886 |
| Every Cure Inc | PA | $54,466,208 | $465,529 |
| Hennepin Healthcare Research Institute | MN | $54,717,221 | $58,740 |
| Critical Path Institute | AZ | $42,610,862 | $459,407 |